Personalisation could improve bile duct cancer treatments

Treatment of patients suffering from bile duct cancer could be improved by tailoring medication to the levels of a key protein in people with the disease, according to new research. Cholangiocarcinoma (CCA) is a deadly disease with few treatments, but researchers in the UK and Thailand have discovered that the PRH/HHEX protein is a key … Continue reading “Personalisation could improve bile duct cancer treatments”

How do antibodies target dangerous bacteria? New study reveals how…

A new study from BHP founder member the University of Birmingham has helped provide novel understanding into how to select antigens to target in vaccines or new treatments against bacterial infections. Published in Nature Communications, scientists describe why some antibodies to bacterial proteins are protective, while others are not. Protection against bacteria afforded by natural infection … Continue reading “How do antibodies target dangerous bacteria? New study reveals how…”

“Millie” award win for research centre

The Scar Free Foundation has won one of The Sun’s prestigious Military Awards for pioneering research carried out in partnership with BHP founder members UoB and UHB, aiming to advance the rehabilitation and recovery of injured servicemen and women. Prime Minister Boris Johnson helped hand out the awards – affectionately dubbed the Millies – which … Continue reading ““Millie” award win for research centre”

Urgent improvements needed in care of paediatric appendicitis

Thousands of UK children undergo unnecessary appendix surgery each year in the NHS, according to a new study by BHP researchers. Surgery for appendicitis is the most common emergency operation in children. A new study has found that the UK has the highest reported national rate of ‘normal appendicectomy,’ where children undergo surgery for suspected … Continue reading “Urgent improvements needed in care of paediatric appendicitis”

Antigens developed to aid fightback against coronavirus

The Native Antigen Company, one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, has announced the commercial introduction of its Novel Coronavirus antigens, derived from the emerging Wuhan strain. These recombinant proteins offer scientists high-quality reagents to support ongoing infectious disease research, and … Continue reading “Antigens developed to aid fightback against coronavirus”